JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, H. J.
Right arrow Articles by Bray, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, H. J.
Right arrow Articles by Bray, G. A.
Journal of the American College of Nutrition, Vol. 21, No. 3, 259-267 (2002)
Published by the American College of Nutrition


Original Research

Effect on Body Weight of Replacing Dietary Fat with Olestra for Two or Ten Weeks in Healthy Men and Women

Heli J. Roy, PhD, Marlene M. Most, PhD, Andrea Sparti, PhD, Jennifer C. Lovejoy, PhD, Julia Volaufova, PhD, John C. Peters, PhD and George A. Bray, MD

1 Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana (H.J.R., M.M.M., A.S., J.C.L., J.V., G.A.B.)
2 Regulatory and Clinical Development, The Procter & Gamble Co., Cincinnati, Ohio (J.C.P.)

Address reprint requests to: Marlene M. Most, PhD, RD, FADA, Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808. E-mail: mostmm{at}pbrc.edu


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Objective: To examine in two separate studies the effects of replacing dietary fat with Olestra on body composition and weight change in healthy young men and women.

Methods: Ten healthy, lean young men participated in Study One that was a 22-day single blind, within-subject design. After a control diet (40% fat) for eight days Study One subjects received an Olestra-substituted diet (31% metabolizable fat) for 14 days. Study Two was a randomized parallel-arm clinical trial with 15 healthy, lean and overweight young women. These subjects were randomly assigned to receive a control diet (40% fat), an Olestra-containing diet (31% metabolizable fat) or a reduced-fat diet (31% fat) for 10 weeks. All foods were provided to the subjects, and energy intakes were not restricted. The primary endpoint in both studies was change from baseline in body weight. In Study Two, body composition was measured by dual energy x-ray absorptiometry. In both studies, food intake and nutrient compensation were assessed.

Results: In Study One fat substitution by Olestra resulted in a significant 1.7 kg weight loss from baseline. In Study Two, change in body weight and body fat from baseline were statistically significant in all groups, but the group with Olestra lost significantly more weight from baseline (-5.0 kg) than the other two groups. In Study One there was partial compensation for the decreased energy intake, while in Study Two, compensation was seen only for those on the reduced-fat diet.

Conclusion: Replacement of 1/3 of dietary fat with Olestra in periods of up to 10 weeks results in weight loss in men and women.

Key words: body weight, dietary fat, energy intake, fat substitute


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Dietary fat has been implicated in the development of obesity [14]. In a cross-cultural comparison, dietary fat and obesity are strongly associated [1]. Within-country data also illustrate that as the level of fat in the diet increases, the prevalence of obesity increases [5,6]. Because fat is highly energy dense, diets that are high in fat are typically high-energy as well. In the absence of adequate physical activity, high-energy diets promote obesity. Whether reducing dietary fat is a useful strategy in the treatment of obesity is less clear, although several short-term clinical trials have shown that low fat diets promote weight loss (reviewed in [1]).

Olestra provides a valuable tool with which to explore the changes in metabolism and food intake when energy density of the diet is covertly reduced without altering the mass or mouth-feel of the food. The replacement of dietary fat with Olestra produces an energy deficit that must be met by mobilizing fat reserves or by increasing food intake if weight loss is to be prevented. If the energy deficit produced by reducing metabolizable energy from fat is detected when other properties of the diet remain the same, then compensation might be expected to result in an increase in food intake. Previous studies examining the impact of Olestra on energy balance suggest that energy deficits on Olestra-containing diets are poorly compensated and could lead to weight loss [7]. However, previous studies were all short-term and investigations of effects of Olestra on substrate oxidation are lacking. We examined these concepts in two separate studies. In the first study, the effects of replacing dietary fat with Olestra were examined in young men who spent two periods of two days each in a metabolic chamber where the short-term effects of Olestra on fat oxidation and total energy expenditure could be measured. Only the weight change and food intake data are reported here. The observation of weight loss in the two-week interval between the two respiratory chamber stays in Study One prompted the second 12-week study of Olestra in a group of lean and obese females.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Subjects
Study One.
Ten lean, healthy young men, ages 18 to 35 years, with a body mass index (BMI) of <25 kg/m2 were recruited to participate in a study using the respiration chamber where the effects of acute replacement with Olestra on metabolic rate and fat oxidation could be assessed. They were weight stable within 1 kg for the six months prior to the study. The subjects were not restrained eaters as measured by the Three Factor Eating Questionnaire [8], and they regularly ate three meals a day. Men were excluded if they had eating disorders, a family history of obesity or diabetes, had chronic illness, were taking medications, were dieters or experienced weight cycles, or were consuming vegetarian or unusual diets. Smokers and athletes also were excluded.

Study Two.
Eighteen healthy, young women, aged 18 to 30 years, with a BMI of 21 to 35 kg/m2 were recruited. They were weight stable for six months prior to the study, and regularly ate three meals a day. Women who were highly restrained eaters based on the Three Factor Eating Inventory [8] were excluded from the study. Additional factors for exclusion were diabetes, smoking, vegetarianism, athletic training, and medications other than oral contraceptives, gastrointestinal (GI) problems or surgery other than cholecystectomy or appendectomy, or a family history of obesity. Three women dropped out prior to completion of the study and were not used in the analyses. One subject experienced GI symptoms with consumption of Olestra, one had GI symptoms unrelated to Olestra, and one dropped out for personal reasons. This left 15 subjects who completed the study.

The Institutional Review Board of Louisiana State University approved both protocols and informed consent was obtained from all participants.

Experimental Design
Study One.
During the first eight days all subjects received a control diet prior to entering the respiration chamber. After the first 24 hours in the chamber, the diet was modified by the replacement of 1/3 of the fat with Olestra. After an additional 24 hours, the subjects were discharged and given the Olestra-substituted diet as outpatients for an additional 14 days. For the final two days the subjects stayed in the respiration chamber to evaluate metabolic rate and fat oxidation (data not reported here). The energy needs for each subject were calculated before preparing their diets. The control diet brought all subjects to the same macronutrient composition prior to the experimental diet, so that each subject’s habitual diet would not confound the results. Body weight, without shoes and in light indoor clothing, was measured weekly in the morning, in the fasting state, and after voiding, using a calibrated electronic scale (National Control, model 3003, Santa Rosa, CA). Initial body composition was assessed by dual energy x-ray absorptiometry (Hologic, QDR2000, Waltham, MA). All subjects could eat as much of the Olestra-containing diet as they wished during the outpatient period, and no effort was made to modify their intake.

Study Two.
This was a randomized controlled trial with three parallel arms. During the first week all subjects consumed the control diet. They were then randomly assigned to one of three diets (the control diet, the Olestra-substituted diet or the reduced-fat diet containing the same metabolizable fat as in the Olestra-substituted diet) for 10 to 12 weeks. The variation in total study length for the women occurred due to the fact that the endpoint tests were performed at the same time of the menstrual cycle phase as baseline testing. Body weight was measured as in Study One, while lean body mass and fat mass were assessed at the beginning, middle and end of the study by dual energy x-ray absorptiometry (DXA). Although the subjects were randomly assigned to the diet arms, an imbalance in starting body weight occurred, and, as by chance, only lean subjects were randomized to the reduced-fat arm.

Diets
Study One.
The control diet provided 40% of the energy as fat, 45% as carbohydrate and 15% as protein [9]. The total fat level was near the average intake of the population at the time of the study. The Olestra diet had 1/3 less absorbable fat than the control diet, but equal amounts of carbohydrate and protein (Fig. 1). Therefore, the metabolizable energy was approximately 13% less than the control diet, and the composition of the macronutrients changed, providing 31% of the metabolizable energy from fat, 52% from carbohydrate and 17% from protein. The Olestra diet was less energy dense than the control diet since the same volume provided 87% of the energy provided by the control diet. The subjects knew that Olestra was to be used during the study, but were unaware of what foods contained it.



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1. Example macronutrient content of the diets for Study One.

 
Study Two.
The control and Olestra diets were of the same composition as in Study One. The reduced-fat diet matched the macronutrient composition of the Olestra diet. For all three diets, total grams of protein and carbohydrate were similar, while total grams of metabolizable fat were similar for the Olestra and reduced-fat diets (Fig. 2). The reduced-fat diet was lower in total weight than the control and Olestra diets, but since the metabolizable energy for the reduced-fat diet was similar to the Olestra diet, their energy densities were similar and less than the control diet. The subjects were told that Olestra, a fat substitute was used in one arm of the study, but they did not know who was receiving the fat substitute. All subjects received a multi-vitamin tablet daily to maintain fat-soluble vitamin status.



View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2. Example macronutrient content of the diets for Study Two.

 
For both studies, all subjects received an obligatory diet that they were required to consume in entirety based on their initial individualized energy intake level. Free choice foods (described below) were available for each subject to eat as desired to adjust their energy intake. Initial energy intake levels were estimated for each subject from the resting metabolic rate and multiplied by an activity factor (1.5 for Study One and 1.4 for Study Two). Observations in our laboratory have shown that women have a lower activity factor than men (range 1.1 to 1.7 for women vs. 1.3 to 1.85 for men) [10]. During the first week of each study, while all subjects were on the control diet, total energy intake was adjusted until the level required for weight maintenance was achieved. That energy level was provided to those on the control diet (Study Two). When the subjects received the Olestra-substituted (Study One and Two) or reduced-fat (Study Two) diets, they received essentially similar diets, but with approximately 13% less energy (e.g., approximately 270 kcal less for a 2000 kcal diet, 360 kcal less for a 2700 kcal diet). With the availability of the free choice foods, those subjects had the possibility to compensate for the energy deficit. For subjects remaining on the control diet (Study Two), free choice foods allowed them to maintain energy intake required for weight maintenance. Although the obligatory portion of the diets could have been less, this approach tightly maintained the macronutrient content of the diets, yet provided some leeway for compensation using free choice foods or allowing for weight loss.

For both studies, foods in the Olestra-substituted diet matched those of the control diet, except that 1/3 of the fat (24 to 50 g/day, depending on the energy level) in the diet was replaced by Olestra. Olestra replaced cooking oils and hydrogenated shortening in baked products and entrees. Menus were analyzed using the Moore’s Extended Nutrient (MENu) database (Pennington Biomedical Research Foundation, Baton Rouge, LA). Sample menus are shown in Table 1. All food was prepared by the Metabolic Kitchen staff of the Pennington Biomedical Research Center under the supervision of a research dietitian. The subjects were required to eat two meals a day, usually breakfast and dinner, at the center. Lunch, the evening snack and all weekend meals were packed for take-out.


View this table:
[in this window]
[in a new window]
 
Table 1. Sample Menus Used for Study Two

 
The free choice foods (crackers, muffins, dinner rolls, cornbread muffins and biscuits) had the same macronutrient composition as the overall diet. Control diet free choice foods were 100 kcal each, while Olestra-containing and reduced-fat free choice foods were 87 kcal each. Subjects received free choice foods in excess with every meal and as snacks. They could eat as much or as little of the free choice foods as desired. This system allowed the subjects to freely vary their energy intake without affecting the macronutrient composition of the diet [11]. Non-caloric beverages were allowed ad libitum.

Use of a daily diary assessed adherence to the diet. All participants were asked to record study foods and beverages not consumed and non-study foods consumed. Although this is self-reported data, which depends on the honesty of the subjects, the dietary staff worked to establish an environment of trust to promote accurate reporting. Reported deviations were used to adjust dietary intake data.

To assess whether it was possible to detect the Olestra included in the food, prior to the study a panel of Pennington Biomedical Research Center staff conducted blinded paired-sample food tasting sessions. Sensory attributes and overall flavor acceptability for each Olestra and full-fat food product were rated. The taste panel members were asked to identify in each pair of foods the one they thought contained Olestra. The results showed that it was not possible to differentiate between the Olestra and the full-fat versions of the foods (data not shown).

Statistical Analysis of Data
Study One.
The response variables were analyzed using an analysis of variance (ANOVA) with repeated measures design, with two different types of repeated factor. One was the day (with five levels) and the other was the period (with two levels) referring to period one as a control and period two as treatment. In both cases the five dimensional covariance matrix of measurements was modeled as unstructured.

Study Two.
There were two types of analysis conducted. The repeated measures analysis was used for comparison of two periods (weeks 0 to 4 and weeks 5 to 10), adjusted for baseline body weight. For response variables that were taken at baseline, midpoint and end, such as fat mass and lean body mass, a simpler analysis was conducted, analyzing the change from baseline adjusted for baseline as a covariate with two levels of repeated factor.

In both studies, the baseline body weight was used as a covariate in body weight change analysis. Statistical analyses (Proc MIXED) were done on a personal computer using SAS for Windows, 6.12 (SAS, Inc. Cary, NC). An alpha <0.05 was considered significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Study One.
Characteristics for the 10 healthy, lean, nonsmoking, young men are shown in the left-hand column of Table 2. Energy and nutrient intakes were affected by the dietary manipulation (Table 3). Olestra substitution for regular fat resulted in a significant reduction in energy intake of 244 ± 76 kcal/day. No effect of time on energy intake could be detected during the control (p = 0.25) or Olestra diet (p = 0.13). Digestible fat intake decreased significantly going from control to the Olestra diet. With Olestra substituting for 1/3 of the dietary fat, the expected fat intake was 79 g/day without any compensatory response. However, due to a partial compensation, metabolizable fat intake was significantly higher by 5 g/day (p < 0.002). Carbohydrate intake also was significantly higher than the calculated intake of 309 g/day (p < 0.03). However, there was no significant difference in carbohydrate intake between the control and Olestra diet periods (Table 3). Protein intake did not change. Within the control or Olestra diet periods, there was no significant effect of day on nutrient intakes (ANOVA, p > 0.6 for all variables).


View this table:
[in this window]
[in a new window]
 
Table 2. Baseline Characteristics of Participants

 

View this table:
[in this window]
[in a new window]
 
Table 3. Average Macronutrient Intakes for Study One

 
Mean (± standard error) baseline body weight was 71.8 ± 2.0 kg (Table 2). Weight reduction was observed during the Olestra diet, at weeks one and two of the intervention (70.8 ± 2.0 kg and 70.1 ± 2.0 kg, respectively; p < 0.0001). With the exception of one, all subjects lost weight on the Olestra diet (Fig. 3), and there was a significant effect of study week on body weight (p < 0.003) with weight loss becoming statistically significant by the end of the Olestra diet.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3. Weight loss for each participant and mean weight loss denoted with an asterisk (*) during Study One (difference from control diet).

 
Study Two.
The subject characteristics are shown in the right three columns of Table 2. Randomization did not result in groups that were equally matched. Both lean and obese women were included in the control and Olestra arms, while only lean women (BMI ~20 to 23 kg/m2) were randomized to the reduced-fat arm. Although the subjects were randomly assigned, this is never an assurance that the groups are not different on some traits as proved to be the case here. Nevertheless, at baseline, there were no significant differences among groups for weight or any other variable due to the larger variance with the small sample size.

The average daily energy and nutrient intakes are shown in Table 4. Energy intakes, when adjusted for baseline body weight, for subjects consuming the Olestra and reduced-fat diets were significantly lower than intakes for those consuming the control diet. For those consuming the Olestra and reduced-fat diets, energy intake was less during weeks 5 to 10 than during the first half of the study. Energy intake did not change over time for the control subjects. Digestible fat intake differed among each of the diets and did not change over time. It was lowest for those on the Olestra diet, followed by that for the reduced-fat diet. Carbohydrate and protein intakes were significantly lower for those on the Olestra diet compared to the other diet groups.


View this table:
[in this window]
[in a new window]
 
Table 4. Average Macronutrient Intakes for Study Two

 
The reduction in total energy intake for the Olestra and reduced-fat diet groups was expected to be similar (13% of estimated energy for weight maintenance). However, compensation occurred for those on the reduced-fat diet. Daily energy intake was significantly higher (p < 0.0001) than expected due to significantly higher intakes of fat, carbohydrate and protein than expected if there had been no compensation. Metabolizable fat intake was significantly higher than expected for the Olestra group (by 10 g/day) throughout the study for both periods. Similarly, the control group consumed more fat than expected: 7.5 g/day during the first period (p < 0.002) and 4.6 g/day during the last period (p < 0.03).

Mean weight loss (± standard error) for each diet group is shown in Fig. 4. All subjects lost weight during the study (p < 0.0001). From weeks 5 to 10, women in the control group had no further reduction in weight (p = 0.19). Women in the Olestra group lost significantly more weight (p < 0.0001) than did those on the reduced-fat diet (p = 0.01). The observed weight loss was due to significant loss of body fat over time (Table 5). From weeks 5 to 10 the Olestra group had a significant loss of fat mass (in kg), while the reduced-fat and control diet groups did not. There were no significant differences in lean body mass between groups or over time.



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4. Weight loss (mean ± standard error) during Study Two (difference from control diet). Between weeks 5 and 10 denoted with an asterisk (*) weight loss for control is NS and significant for reduced fat (p < 0.01) and Olestra groups (p < 0.0001).

 

View this table:
[in this window]
[in a new window]
 
Table 5. Body Composition Measurements (Body Fat, Fat Mass, and Lean Body Mass) for Study Two

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Previous short- and intermediate-term studies with Olestra substitution have shown that energy reduction is made up by increased food intake [1214]. Other studies [1518] did not find differences in daily energy intake following a replacement of fat with sucrose polyester in a single meal. In studies lasting 14 to 20 days, lean and obese men and women failed to compensate completely for the reduced fat and energy in the diet when they consumed Olestra-containing food throughout the day [19,20]. Both of the experiments reported here show incomplete compensation and suggest that covert replacement of dietary fat with Olestra results in significant and sustained reduction in energy intake and weight loss.

Reduction in the digestible fat by 1/3 with Olestra in the diet of healthy men (approximately 13% of energy) resulted in a weight loss, which became statistically significant at the end of the 14-day intervention. A reduction of dietary fat from the control to the Olestra diet reduced energy intake by nearly 250 kcal/day. If this energy deficit was obtained from adipose tissue triglyceride stores, 36 g of fat would be metabolized each day (250 kcal divided by 7 kcal/g for adipose tissue). This would have produced during the 14 days of intervention a total loss of about 500 g or 0.5 kg. The mean weight loss was 1.0 kg, suggesting that some non-triglyceride stores and water were also lost.

The fact that the healthy men in the first experiment did not eat enough of the free choice foods to make up for the loss of metabolizable fat energy has two implications. First, it suggests, as have several other studies [21,22], that subjects eat to maintain the mass of food. Second, it suggests that in the short term, the calories lost as fat are not detected metabolically. The small, but significant weight loss in these healthy young men suggests that perhaps in the short run, gastric distention signals may be more important than those which arise from the hormonal signals generated in the intestinal milieu or from an energy deficit [22].

The second experiment extended the study of covert fat replacement to women over a longer period of time (~10 weeks). The weight loss of the women eating the Olestra-substituted diet during the last six weeks of the study was significantly greater than the other two groups. As described above, if 36 g of fat from fat stores were needed each day to compensate for the energy deficit, one would anticipate over 10 weeks a loss of approximately 2.5 kg as adipose tissue triglyceride. Subjects in the Olestra group lost 5 kg of body weight by 10 weeks, similarly suggesting the loss of additional non-triglyceride stores and water. Again, free choice foods were not used to compensate for the lost calories from fat in the Olestra group. This leads us to conclude that covert replacement of fat by a fat substitute and the resulting daily withdrawal of small amounts of fat from body fat stores is not detected by the body. Conversely, compensation did occur for those consuming the reduced-fat diet, and their weight loss was less than that of the women consuming an Olestra diet. The fat substitute masked detection of daily changes in fat balance. The subjects may have been compensating for the volume of food, as suggested by Rolls et al. [23]. The compensation that occurred in Study Two is consistent with the compensation reported in other studies above.

It is possible that compensation was seen only for those on the reduced-fat diet because all subjects in that group were lean, whereas obese subjects were included in the other two diet groups. Additionally, we cannot overlook the inclusion of obese women in the Olestra group and the fact that the greatest weight loss occurred for this group. Although it might be tempting to believe these subjects had more incentive to lose weight, the control group also included obese women and energy intakes were not restricted. When comparing the weight loss of the Olestra group to that of the control group, the Olestra group lost significantly more during the last part of the study while the control group had no further reduction in weight.

The subjects selected for both studies had been weight stable for quite some time before the studies started. All subjects were assumed to be "good regulators" of their body weight. The basic hypothesis was that these subjects would detect easily the change in energy content of the food, or the change in their energy stores, and would then adjust their food intake accordingly. The study design, i.e., the presence of the freely available "free choice" foods, allowed them to do so. However, they did not fully compensate for the energy deficit when dietary fat was covertly replaced with Olestra.

A number of studies have examined diets differing in fat content on weight loss [10,2431]. In many, fat content of the diet was reduced, resulting in an increased carbohydrate content, so that high fat diets were then compared to high carbohydrate diets. In this respect they differ from the fat substitution studies where a fat substitute contributes no energy to the food and can "hide" the lower energy content of the diet in terms of energy density and hedonic properties. The aforementioned studies have shown that high carbohydrate diets are associated with lower energy intake or loss of body weight. This is also supported by cross sectional studies showing a positive correlation between dietary fat intake and body fatness [3235]. In reviews by Bray and Popkin [1] and Lissner and Heitman [2] cross-cultural comparisons and cross-sectional, prospective and randomized trials have all provided data consistent with the idea that higher dietary fat resulted in higher body fat. Lissner et al. [26] showed that simply reducing the fat content of the diet resulted in a loss of calories that was uncompensated, leading to weight loss. In a longer-term study where subjects had free choice to compensate, Kendall et al. [25] found that subjects compensated for only 35% of the reduced calories after 11 weeks. Thus, our studies showing weight loss and incomplete compensation for the reduction in metabolizable fat content of the diets are consistent with the findings of other studies of dietary fat reduction.

In summary, the present report indicates that reduction in dietary fat content through fat replacement with Olestra results in significant reduction in energy intake and body weight in both men and women.


    CONCLUSIONS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
The use of Olestra allowed examination of changes in food intake when energy density is reduced without altering total volume of food and physical properties related to dietary fat. A better understanding of the contributions of dietary fat to obesity will allow health professionals to determine whether reducing dietary fat is a useful strategy in the treatment of obesity. The diet manipulations in these studies were associated with a reduction in fat from 40% of total energy to approximately 30% of energy, both within the range of diet composition consumed in the US. Our data indicate that a covert energy deficit is not detected. The replacement of 1/3 of the dietary fat with Olestra in periods of up to 10 weeks results in loss of body weight and fat in both men and women. On average, only a minor adjustment of food intake was observed during covert fat substitution with Olestra. Greater compensation, but still incomplete, occurred with a more traditional reduced-fat diet.


    ACKNOWLEDGMENTS
 
This work was supported by the USDA (ACSRS 91-34115-6148). Procter & Gamble Company donated the Olestra.

The authors thank the study volunteers for their time and effort, without whom these studies would not have been possible. Additionally, we are indebted to Jana Ihrig, RN, for her coordination of the studies and to Helena Duplantis, RD, Camilla Ostrowe, Michelle Barkate, RD and the staff of the Pennington Center Metabolic Kitchen for the food preparation and the diet analysis. Finally, we are grateful to all the Clinical Trials staff members for their contributions to the research.


    FOOTNOTES
 
Heli J. Roy, PhD, is presently at Louisiana State University Agricultural Center, Baton Rouge, Louisiana. Andrea Sparti, PhD, is presently at the Swiss Federal Office of Public Health, Bern, SWITZERLAND. Preliminary data were presented at the Experimental Biology meetings (FASEB J 11:A358, 1997; 9:A439, 1995) and the American Society for Clinical Nutrition meeting (Am J Clin Nutr 61:902, 1995).

Received August 30, 2001. Accepted March 25, 2002.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 

  1. Bray GA, Popkin BM: Dietary fat intake does affect obesity! Am J Clin Nutr68 :1157 –1173,1998 .[Abstract]
  2. Lissner L, Heitman BL: Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr49 :79 –90,1995 .[Medline]
  3. Golay A, Bobbioni E: The role of dietary fat in obesity. Int J Obes21(Suppl) :S2 –S11,1997 .
  4. Willett WC: Is dietary fat a major determinant of body fat? Am J Clin Nutr67(Suppl) :556S –562S,1998 .[Abstract]
  5. Sonne-Holm S, Sorensen TIA: Post-war course of the prevalence of extreme overweight among Danish young men. J Chron Dis30 :351 –358,1977 .[Medline]
  6. Blundell JE, Macdiarmid JI: Fat as a risk factor for overconsumption: satiation, satiety, and patterns of eating. J Am Diet Assoc97(Suppl) :S63 –S69,1997 .[Medline]
  7. Stubbs RJ: The effect of ingesting Olestra-based foods on feeding behavior and energy balance in humans. Crit Rev Food Sci Nutr41 :363 –386,2001 .[Medline]
  8. Stunkard AJ, Messick S: The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res29 :71 –83,1985 .[Medline]
  9. Roy HJ, Lovejoy JC, Keenan MJ, Bray GA, Windhauser MM, and Wilson JK: Substrate oxidation and energy expenditure in athletes vs. nonathletes consuming isoenergetic high and low fat diets. Am J Clin Nutr7 :405 –411,1998 .
  10. Roy HJ, Lovejoy JC: Improvements in matching energy expenditure to food intake in a metabolic chamber utilizing prior measurements of free living activity. In Champagne CM (ed): "21st National Nutrient Databank Conference Proceedings." Baton Rouge: Pennington Biomedical Research Center Medical Foundation,1996 .
  11. Thomas CD, Peters JC, Reed GW, Abumrad NN, Sun M, Hill JO: Nutrient balance and energy expenditure during ad libitum feeding of high-fat and high-carbohydrate diets in humans. Am J Clin Nutr55 :934 –942,1992 .[Abstract/Free Full Text]
  12. Rolls BJ, Pirraglia PA, Jones MB, Peters JC: Effects of Olestra, a noncaloric fat substitute, on daily energy and fat intakes in lean men. Am J Clin Nutr56 :84 –92,1992 .[Abstract/Free Full Text]
  13. Burley VJ, Blundell JE: Evaluation of the action of a non-absorbable fat on appetite and energy intake in lean, healthy males. Int J Obes15(Suppl) :S8 ,1991 .
  14. Birch LL, Johnson SL, Jones MB, Peters JC: Effects of a nonenergy fat substitute on children’s energy and macronutrient intake. Am J Clin Nutr58 :326 –333,1993 .[Abstract/Free Full Text]
  15. Hulshof T, De Graaf C, Westrate JA: The effects of preloads varying in physical state and fat content on satiety and energy intake. Appetite21 :273 –286,1993 .[Medline]
  16. Hulshof T, De Graaf C, Weststrate JA: Short-term effects of high-fat and low-fat/high-SPE croissants on appetite and energy intake at three deprivation periods. Physiol Behav57 :377 –383,1995 .[Medline]
  17. Hulshof T, De Graaf C, Weststrate JA: Short-term satiating effect of the fat replacer sucrose polyester (SPE) in man. Br J Nutr74 :569 –585,1995 .[Medline]
  18. Cotton JR, Burley VJ, Blundell JE: Effect on appetite of replacing natural fat with sucrose polyester in meals or snacks across the whole day [Abstract]. Int J Obes17(Suppl) :S47 ,1993 .
  19. Glueck CJ, Hastings MM, Allen C, Hogg E, Baehler L, Gartside PS, Phillips D, Jones M, Hollenbach EJ, Braun B, Anastasia JV: Sucrose polyester and covert caloric dilution. Am J Clin Nutr35 :1352 –1359,1982 .[Abstract/Free Full Text]
  20. Hill JO, Seagle HM, Johnson SL, Smith S, Reed GW, Tran ZV, Cooper D, Stone M, Peters JC: Effects of 14 d of covert substitution with Olestra for conventional fat on spontaneous food intake. Am J Clin Nutr67 :1178 –1185,1998 .[Abstract]
  21. Blundell JE, Cotton JR, Delargy H, Green S, Greenough A, King NA, Lawton C: The fat paradox: fat-induced satiety signals vs. high fat overconsumption. Int J Obes19 :832 –835,1995 .
  22. Sparti A, Windhauser MM, Champagne CM, Bray GA: Effect of an acute reduction in carbohydrate intake on subsequent food intake in healthy men. Am J Clin Nutr66 :1144 –1150,1997 .[Abstract/Free Full Text]
  23. Rolls BJ, Castellanos VH, Halford JC, Kilara A, Panyam D, Pelkman CL, Smith GP, Thorwart ML: Volume of food consumed affects satiety in men. Am J Clin Nutr67 :1170 –1177,1998 .[Abstract]
  24. Duncan KH, Bacon JA, Weinsier RL: The effects of high and low energy density diets on satiety, energy intake and eating time of obese and nonobese subjects. Am J Clin Nutr37 :763 –767,1983 .[Abstract/Free Full Text]
  25. Kendall A, Levitsky DA, Strupp BJ, Lissner L: Weight loss on a low-fat diet: Consequence of the imprecision of the control of food intake in humans. Am J Clin Nutr53 :1124 –1129,1991 .[Abstract/Free Full Text]
  26. Lissner L, Levitsky DA, Strupp BJ, Kalkwarf HJ, Roe DA: Dietary fat and the regulation of energy intake in human subjects. Am J Clin Nutr46 :886 –892,1987 .[Abstract/Free Full Text]
  27. Wooley OW: Long-term food regulation in the obese and nonobese. Psychosom Med33 :436 –444,1971 .[Abstract/Free Full Text]
  28. Stubbs RJ, Harbron CG, Murgatroyd PR, Prentice AM: Covert manipulation of dietary fat and energy density: effect on substrate flux and food intake in men eating ad libitum. Am J Clin Nutr62 :316 –329,1995 .[Abstract/Free Full Text]
  29. Stubbs RJ, Ritz P, Coward WA, Prentice AM: Covert manipulation of the ratio of dietary fat to carbohydrate and energy density: effect on food intake and energy balance in free-living men eating ad libitum. Am J Clin Nutr62 :330 –337,1995 .[Abstract/Free Full Text]
  30. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM: Effects of the national cholesterol education program’s step I and step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr69 :632 –646,1999 .[Abstract/Free Full Text]
  31. Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E, Hill JO: The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br J Nutr83(Suppl) :S25 –S32,2000 .
  32. Dreon DM, Frey-Hewitt B, Ellsworth N, Williams PT, Terry RB, Wood PD: Dietary fat:carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr47 :995 –1000,1988 .[Abstract/Free Full Text]
  33. Tucker LA, Kano MJ: Dietary fat and body fat: a multivariate study of 205 adult females. Am J Clin Nutr56 :616 –622,1992 .[Abstract/Free Full Text]
  34. Hill JO, Yakubu F, Peters JC: Development of dietary obesity in rats: influence of amount and composition of dietary fat. Int J Obes16 :321 –333,1992 .
  35. Lovejoy J, DiGirolamo M: Habitual dietary intake and insulin sensitivity in lean and obese adults. Am J Clin Nutr55 :1174 –1179,1992 .[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. L Neuhouser, C. L Rock, A. R Kristal, R. E Patterson, D. Neumark-Sztainer, L. J Cheskin, and M. D Thornquist
Olestra is associated with slight reductions in serum carotenoids but does not markedly influence serum fat-soluble vitamin concentrations
Am. J. Clinical Nutrition, March 1, 2006; 83(3): 624 - 631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. W Krieger, H. S Sitren, M. J Daniels, and B. Langkamp-Henken
Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression 1
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 260 - 274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. A Bray, J. C Lovejoy, M. Most-Windhauser, S. R Smith, J. Volaufova, Y. Denkins, L. de Jonge, J. Rood, M. Lefevre, A. L Eldridge, et al.
A 9-mo randomized clinical trial comparing fat-substituted and fat-reduced diets in healthy obese men: the Ole Study
Am. J. Clinical Nutrition, November 1, 2002; 76(5): 928 - 934.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, H. J.
Right arrow Articles by Bray, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, H. J.
Right arrow Articles by Bray, G. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS